The data indicate a higher degree of PR3-catalyzed elastin degradation in IBD patients and a higher degree of MMP-12-catalyzed degradation in CD patients, which was not evident in UC patients (Figure 2). Here, PRTN3 is linked to inflammatory bowel disease.